A Pharmacy-based Observational Study to Learn More About Iberogast Advance in the Real-world Setting

NCT05389709 · clinicaltrials.gov ↗

COMPLETED

Status

184

Enrollment

INDUSTRY

Sponsor class

Conditions

Functional Gastrointestinal Disorders Such as Irritable Bowel Syndrome and Functional Dyspepsia
Irritable Bowel Syndrome
Functional Dyspepsia

Interventions

DRUG: Iberogast (STW5-II, BAY98-7410)

Sponsor

Bayer